WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3201 Infant (under 12 months) mortality rate: 912
GDP / capita (US$): 6041 Child (under 5 years) mortality rate: 1292

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'616  4'525  4'436  4'350  4'266  3'638  2'913  2'274 
Births 158  156  155  153  151  143  120  97 
Surviving infants 143  142  140  138  136  127  106  86 
Pop. less than 5 years 674  662  653  646  640  591  496  385 
Pop. less than 15 years 1'839  1'815  1'791  1'768  1'747  1'539  1'261  961 
Female 15-49 years 1'145  1'116  1'088  1'060  1'034  856  660  519 

Number of reported case

(Click for retrospective incidence data for Central African Republic (the))
Diphtheria 35 
Japanese encephalitis
Measles 596  141  679  11  3'207  1'275  8'280 
Mumps
Pertussis 124  124  100  63  46  4'340 
Polio* 14  28  21 
Rubella 31  11  15  15  32 
Rubella (CRS)
Tetanus (neonatal) 68  65  49  20  15  37  32 
Tetanus (total) 68  74  49  20  15  37  34  217 
Yellow fever 29 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Central African Republic (the))
Vaccine year result method % card seen                                                
BCG 2011  74  EPI   50  39  61  69  64  87  47  93  17 
DTP1 2009  65  MICS   32  44  78  84  71  99*  46 
DTP3 2011  47  EPI   50  28  59  64  58  76  29  61  13 
HepB_BD         
HepB3 2011  47  EPI   50  28  58  64  58  76 
Hib3 2011  47  EPI   50  28  58  64  58  76 
JapEnc         
MCV 2011  49  EPI   50  29  65  80  62  94  34  67  12 
MCV2         
PCV1          32  75  38 
PCV3          20  52 
Pol3 2011  71  EPI   50  28  55  67  58  76  31  57  13 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  53  MICS   32  33  76  81  50  99*  20  65 
PAB         
VAD1          13  19 
YFV 2011  48  EPI   50  29  64  79  64  93  19 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Central African Republic (the))
BCG 37  74  74  74  74  66  96  17 
DTP1 35  69  69  67  65  60  95  35 
DTP3 23  47  47  45  42  37  82  13 
HepB3 23  47  47  45  42 
HepB_BD
Hib3 23  47  47  45  42 
MCV 25  49  49  53  56  36  82  12 
MCV2
PAB 66  66  80  86  86  36  69 
PnC3 23  47 
Pol3 23  47  47  46  45  38  82  13 
Rota_last
YFV 24  48  48  55  62  36 

Number of districts in the country 24  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
86 
   
/
|
|
\
Greater or equal to 90% 4
From 80 to 89% 0
From 50 to 79% 21
Less than 50% 75
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2008 - 2012  2008-2012  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 24  24  24  24  24  24  24 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  Yes       

System performance

Total Nº districts in country number 24  24  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 13  33  13  38  21 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 38  13   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  No  No  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 1'783  74 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.